Recently acquired hepatitis C virus infection among people living with human immunodeficiency virus at a university hospital in Taiwan

Table 1 Clinical characteristics of people living with human immunodeficiency virus who had incident hepatitis C virus infection from 2011 to 2018

Clinical characteristics	n = 287
Age, mean ± SD, yr	34.5 ± 7.6
Male sex, n (%)	287 (100)
Risk group, n (%)
Men who have sex with men	265 (92.3)
Heterosexuals	5 (1.8)
Injecting drug users	4 (1.4)
Unknown	13 (4.5)
HIV PVL, mean ± SD, log10 copies/mL	1.72 ± 1.09
CD4 count, mean ± SD, cells/mm3	597.7 ± 251.1
HBsAg-positive, n (%)	42 (14.9)
Syphilis, n (%)	256 (89.2)
Plasma HCV RNA, mean ± SD, log10 copies/mL	5.72 ± 1.50)
HCV genotype, n (%)
1a	22 (7.7)
1b	84 (29.3)
2a	119 (41.5)
3	6 (2.1)
6	34 (11.8)
Mixed genotype 1b+2	3 (1.0)
No data	19 (6.6)
Year of seroconversion, n (%)
2011	23 (8.0)
2012	28 (9.8)
2013	27 (9.4)
2014	24 (8.4)
2015	31 (10.8)
2016	43 (14.9)
2017	54 (18.8)
2018	57 (19.9)

HBsAg: Hepatitis B surface antigen; HCV: Hepatitis C virus; HIV: Human immunodeficiency virus; PVL: Plasma viral load; RNA: Ribonucleic acid.